These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22323339)

  • 21. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.
    Eilertsen GØ; Van Ghelue M; Strand H; Nossent JC
    Rheumatology (Oxford); 2011 Dec; 50(12):2197-205. PubMed ID: 21984763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene.
    Ip WK; Chan SY; Lau CS; Lau YL
    Arthritis Rheum; 1998 Sep; 41(9):1663-8. PubMed ID: 9751100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus.
    Sari RA; Polat MF; Taysi S; Bakan E; Capoğlu I
    Clin Rheumatol; 2002 Nov; 21(6):520-4. PubMed ID: 12447639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum leptin levels, leptin receptor gene (LEPR) polymorphism, and the risk of systemic lupus erythematosus in Kashmiri population.
    Afroze D; Yousuf A; Ali R; Kawoosa F; Akhtar T; Reshi S; Shah ZA
    Immunol Invest; 2015; 44(2):113-25. PubMed ID: 25383655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study.
    Aghdassi E; Ma DW; Morrison S; Hillyer LM; Clarke S; Gladman DD; Urowitz MB; Fortin PR
    JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):198-208. PubMed ID: 21378249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
    Lee YH; Kim YR; Ji JD; Sohn J; Song GG
    J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of matrix metalloproteinase-1 mRNA in peripheral blood mononuclear cells of systemic lupus erythematosus patients and its relationship with atherosclerosis.
    Zhang HY; Bao SM; Shou WL; Luan HX; Zhang Y; Feng X; Tong DW; Zhang SL; Hu CJ; Zeng XF; Li YZ
    Chin Med J (Engl); 2009 Nov; 122(21):2593-7. PubMed ID: 19951575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
    Font J; Ramos-Casals M; Brito-Zerón P; Nardi N; Ibañez A; Suarez B; Jiménez S; Tàssies D; García-Criado A; Ros E; Sentís J; Reverter JC; Lozano F
    Rheumatology (Oxford); 2007 Jan; 46(1):76-80. PubMed ID: 16801331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polymorphism of gene promotor region for MMP-2 in rheumatoid arthritis].
    Nemec P; Goldbergová M; Swobodnik T; Polásková D; Soucek M; Vasků A
    Vnitr Lek; 2006 Apr; 52(4):348-54. PubMed ID: 16755991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular risk profile in systemic lupus erythematosus: a cross-sectional study of 879 patients].
    He CS; Shi W; Ye ZM; Liang XL; Zhang B; Liu SX
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1910-3. PubMed ID: 22126778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of catalase gene polymorphisms with catalase activity and susceptibility to systemic lupus erythematosus in the Suez Canal area, Egypt.
    Ghaly MS; Ghattas MH; Labib SM
    Lupus; 2012 Oct; 21(11):1244-9. PubMed ID: 22736749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
    Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response.
    Schotte H; Gaubitz M; Willeke P; Tidow N; Assmann G; Domschke W; Schlüter B
    Rheumatology (Oxford); 2004 Nov; 43(11):1357-63. PubMed ID: 15304673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus.
    Robak E; Wierzbowska A; Chmiela M; Kulczycka L; Sysa-Jedrejowska A; Robak T
    Mediators Inflamm; 2006; 2006(1):17898. PubMed ID: 16864898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus.
    Zayed RA; Sheba HF; Abo Elazaem MA; Elsaadany ZA; Elmessery LO; Mahmoud JA; Abdel Rahman DR; Abdou FR
    Ann Clin Lab Sci; 2013; 43(3):289-94. PubMed ID: 23884224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG; Giles I; Lambrianides A; Manson J; D'Cruz D; Schrieber L; March LM; Latchman DS; Isenberg DA; Rahman A
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.